ReviewBreast cancer (Tokyo, Japan)2026

Immune checkpoint inhibition in breast cancer: targeting PD-1/PD-L1 pathway for therapeutic advances.

Yunjin Shin et al.PubMed ↗Publisher ↗

No numbers read from the abstract.